Keyphrases
Diabetic Education
100%
Bococizumab
100%
Small Arteries
100%
Meglitinides
100%
GLP-1 Analogue
100%
Gestational Diabetes Mellitus
100%
Euglycemic Diabetic Ketoacidosis
100%
During Pregnancy
60%
Glycaemia
60%
Lose Efficacy
50%
HbA1c Measurement
50%
Endothelium-dependent Dilation
40%
Drug Class
33%
Gliclazide
33%
Spire
22%
Proprotein Convertase
22%
Vasodilator
20%
Gluteofemoral Fat
20%
Fat Biopsy
20%
Vascular Pathology
20%
Regression Analysis
20%
Carbachol
20%
Overweight Women
20%
Endothelium-dependent
20%
Nitric Oxide Synthase Activity
20%
Body Mass Index
20%
Cardiovascular Risk
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Glycaemia Control
20%
Upper Quartile
20%
High-risk Women
20%
Nitric Oxide Inhibition
20%
Wire Myography
20%
Previous Gestational Diabetes Mellitus
20%
Adverse Pregnancy Outcomes
20%
Inducible Nitric Oxide Synthase
20%
Vascular Stiffness
20%
Structure Stiffness
20%
Vascular Structure
20%
Normal Currents
20%
Dependency Function
20%
Hyperglycemia
20%
Endothelium-independent Dilation
20%
2-year Follow-up
20%
Human Arteries
14%
Vascular Dysfunction
14%
Human Insulin
14%
Hyperinsulinemia
14%
Multinational Trial
11%
Low-risk Patients
11%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Bococizumab
100%
Glucagon-Like Peptide-1
100%
Meglitinide
100%
Diabetic Ketoacidosis
100%
Hemoglobin A1c
60%
Gliclazide
50%
Non Insulin Dependent Diabetes Mellitus
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Serine Proteinase
22%
Non Insulin Dependent Diabetes Mellitus
20%
Injection Site Reaction
11%
Unstable Angina Pectoris
11%
Medicine and Dentistry
Glycemic
100%
Artery
100%
Gestational Diabetes
75%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Nitric Oxide Synthase
25%
Biopsy
25%
Hyperinsulinemia
14%
Biopsy Technique
14%
Hyperglycemia
12%
Maturity Onset Diabetes of the Young
12%
Cardiovascular Risk
12%
Vasoconstrictor
12%
Body Mass Index
12%
Obesity
12%
Carbachol
12%
Myography
12%
Blood Vessel
12%
Vascular Disease
12%